
Keywords: Oral immunotherapy; desensitization; sustained unresponsiveness; early intervention; peanut allergy; randomized clinical trial; AE; Adverse event; DBPCFC; Double-blinded, placebo-controlled food challenge; E-OIT; Early intervention oral immunotherapy; 4-S